title: Association of haplotypes of inflammation-related genes with gastric preneoplastic lesions in African Americans and Caucasians.
abstract: Identification of biomarkers is needed for development of screening programs to prevent gastric cancer. Because racial differences exist in cancer rates, we aimed to evaluate the association between polymorphisms in inflammation-related genes and gastric preneoplastic lesions in African Americans and Caucasians from Louisiana, USA. Gastric biopsies from 569 adults (361 African Americans and 208 Caucasians) undergoing diagnostic endoscopy were used for histological diagnosis and genomic DNA extraction. Polymorphisms within eight genes (IL1B, IL8, IL6, TNF, PTGS2, ARG1, IL10 and TGFB1) were investigated by TaqMan. The cagA status of Helicobacter pylori infection was assessed by PCR. Haplotype logistic regression models were used to identify variables associated with intestinal metaplasia or dysplasia. African Americans carrying the haplotype IL1B-511T/-31C/+3954T, which includes the three risk-associated alleles at the IL1B locus, were more likely to being diagnosed with intestinal metaplasia or dysplasia than those carrying the most common haplotype T-C-C (adjusted OR: 2.51, 95% CI: 1.1-5.5). None of the polymorphisms were associated with intestinal metaplasia and dysplasia in Caucasians. Age and cagA-positive status were independent factors associated with these lesions. Haplotypes at the IL1B locus may participate in mediating the susceptibility to gastric carcinogenesis and might be useful as markers of advanced premalignant lesions in African Americans. Interestingly, carriage of IL1B+3954T allele seems to be the key factor, even though the role played by other polymorphisms cannot be excluded.
authors.affiliation: Department of Pediatrics, LSUHSC, New Orleans, LA 70112, USA. jzabal@lsuhsc.edu
authors.forename: Jovanny
authors.initials: J
authors.lastname: Zabaleta
authors.forename: Maria C
authors.initials: MC
authors.lastname: Camargo
authors.forename: Marylyn D
authors.initials: MD
authors.lastname: Ritchie
authors.forename: Maria B
authors.initials: MB
authors.lastname: Piazuelo
authors.forename: Rosa A
authors.initials: RA
authors.lastname: Sierra
authors.forename: Stephen D
authors.initials: SD
authors.lastname: Turner
authors.forename: Alberto
authors.initials: A
authors.lastname: Delgado
authors.forename: Elizabeth T H
authors.initials: ET
authors.lastname: Fontham
authors.forename: Barbara G
authors.initials: BG
authors.lastname: Schneider
authors.forename: Pelayo
authors.initials: P
authors.lastname: Correa
authors.forename: Augusto C
authors.initials: AC
authors.lastname: Ochoa
mesh_terms: D000328:Adult; D044383:Black People / Q000235:genetics*; D015992:Body Mass Index; D004273:DNA, Neoplasm / Q000235:genetics / Q000302:isolation & purification; D005260:Female; D005753:Gastric Mucosa / Q000473:pathology; D006239:Haplotypes; D016481:Helicobacter Infections / Q000150:complications / Q000453:epidemiology; D016480:Helicobacter pylori; D006801:Humans; D007249:Inflammation / Q000235:genetics*; D020382:Interleukin-18 / Q000235:genetics; D008145:Louisiana; D008297:Male; D008875:Middle Aged; D011110:Polymorphism, Genetic; D020641:Polymorphism, Single Nucleotide; D011230:Precancerous Conditions / Q000235:genetics*; D013274:Stomach Neoplasms / Q000150:complications / Q000235:genetics* / Q000473:pathology; D044465:White People / Q000235:genetics*; D001741:Black or African American
chemical_list: D004273:DNA, Neoplasm; D020382:Interleukin-18
references.citation: Am J Hum Genet. 2002 Feb;70(2):425-34
references.pmid: 11791212
references.citation: Gastroenterology. 2001 Oct;121(4):823-9
references.pmid: 11606496
references.citation: J Biol Chem. 2000 Jun 16;275(24):18138-44
references.pmid: 10747905
references.citation: CA Cancer J Clin. 2006 Mar-Apr;56(2):69-83
references.pmid: 16514135
references.citation: Hum Mol Genet. 2006 Feb 15;15(4):519-29
references.pmid: 16399797
references.citation: Hum Hered. 2002;53(2):79-91
references.pmid: 12037407
references.citation: Lancet Oncol. 2008 Mar;9(3):279-87
references.pmid: 18308253
references.citation: Cancer Biol Ther. 2008 Feb;7(2):157-62
references.pmid: 18059184
references.citation: Eur J Cancer. 2009 Sep;45(14):2562-8
references.pmid: 19375306
references.citation: Int J Cancer. 2006 Feb 1;118(3):649-57
references.pmid: 16114018
references.citation: Am J Hum Genet. 1998 Dec;63(6):1872-85
references.pmid: 9837839
references.citation: Annu Rev Physiol. 2001;63:49-76
references.pmid: 11181948
references.citation: Am J Surg Pathol. 1996 Oct;20(10):1161-81
references.pmid: 8827022
references.citation: Cancer Epidemiol Biomarkers Prev. 2004 Dec;13(12):2251-7
references.pmid: 15598788
references.citation: J Microbiol Methods. 2003 Dec;55(3):625-33
references.pmid: 14607406
references.citation: Cancer Causes Control. 2006 Feb;17(1):117-25
references.pmid: 16411061
references.citation: Br J Cancer. 2008 Apr 22;98(8):1443-51
references.pmid: 18319718
references.citation: Genetics. 1997 Oct;147(2):927-30
references.pmid: 9335624
references.citation: Gastroenterology. 2006 Jun;130(7):1975-84
references.pmid: 16762620
references.citation: Gut. 2005 Jun;54(6):764-8
references.pmid: 15888780
references.citation: Biochem J. 2008 Mar 1;410(2):225-35
references.pmid: 18254728
references.citation: J Clin Invest. 2007 Jan;117(1):60-9
references.pmid: 17200707
references.citation: Gut. 2001 Jun;48(6):743-7
references.pmid: 11358884
references.citation: Clin Gastroenterol Hepatol. 2006 Jun;4(6):709-16
references.pmid: 16765306
references.citation: Cancer Epidemiol Biomarkers Prev. 2006 Sep;15(9):1674-87
references.pmid: 16985030
references.citation: Genes Immun. 2006 Dec;7(8):640-6
references.pmid: 16971953
references.citation: Nature. 2000 Mar 23;404(6776):398-402
references.pmid: 10746728
references.citation: Cancer Res. 1995 May 15;55(10):2111-5
references.pmid: 7743510
references.citation: CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108
references.pmid: 15761078
references.citation: Am J Gastroenterol. 1999 May;94(5):1218-23
references.pmid: 10235197
references.citation: Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2631-6
references.pmid: 18086767
references.citation: Eur J Clin Invest. 1992 Jun;22(6):396-402
references.pmid: 1353022
references.citation: Bioinformatics. 2005 Jan 15;21(2):263-5
references.pmid: 15297300
references.citation: Lab Invest. 1995 Dec;73(6):760-70
references.pmid: 8558837
references.citation: Clin Exp Med. 2005 Dec;5(4):169-76
references.pmid: 16362796
references.citation: Lancet. 1975 Jul 12;2(7924):58-60
references.pmid: 49653
references.citation: Am J Gastroenterol. 2006 Jan;101(1):163-71
references.pmid: 16405550
references.citation: Gastroenterology. 2003 May;124(5):1193-201
references.pmid: 12730860
references.citation: IARC Monogr Eval Carcinog Risks Hum. 1994;61:1-241
references.pmid: 7715068
references.citation: Cancer Res. 2004 Aug 15;64(16):5839-49
references.pmid: 15313928
references.citation: Gut. 1998 Feb;42(2):227-34
references.pmid: 9536948
references.citation: Am J Surg Pathol. 2000 Feb;24(2):167-76
references.pmid: 10680883
references.citation: J Clin Invest. 1998 Oct 1;102(7):1369-76
references.pmid: 9769329
references.citation: J Clin Microbiol. 1998 Sep;36(9):2597-603
references.pmid: 9705399
references.citation: CA Cancer J Clin. 2007 Jan-Feb;57(1):43-66
references.pmid: 17237035
references.citation: Int J Cancer. 2007 Mar 15;120(6):1330-5
references.pmid: 17187359
references.citation: Mol Immunol. 1997 Apr;34(5):391-9
references.pmid: 9293772